With the recent introduction of a dietary supplement that has been marketed as a diet supplement, Isotonium, a Japanese-owned company, is moving closer to making dietary supplements as a part of its portfolio.
According to a press release, Isotonsione is “the next step in the development of the dietary supplement market,” with the company hoping to launch a product in the fourth quarter of 2020.
Isotonium will use a “systematic analysis of existing scientific research on dietary supplements,” according to the press release.
The company says the research will help identify the specific ingredients and products that can best be used for supplements.
Isotonix says the system will allow it to determine the best products for each specific user, and then develop and market its own products based on those products.
Isotonic is also developing a product called the Tonic, which is a “dietary supplement with high nutritional value” for the treatment of insomnia, insomnia, and stress.
The company is not the first company to offer a dietary supplements product.
The Food and Drug Administration approved a product from the company last month that is based on the same basic ingredients.
However, a product based on Isotonicsione will have to undergo FDA approval before it can be sold.
The FDA has said it will require a study that assesses the efficacy of the products and whether they provide any long-term benefits to consumers.
The agency is expected to announce a final decision in the coming weeks.